with Yervoy and PD-1 antibody in June 2013 EOM
Sentiment: Strong Buy
And either Merck or BMY will start PD-1/A-7 comb phase 3 in 2014....
. After A-7 is FDA approved....
A-7 plus PD-1 will produce far superior results to Yervoy/PD-1, with fewer AEs.
Vo,correction does much,but encouragement does more.Encouragement after censure is as the sun after a shower.THANKS.
I gave you the first thumbs up on your post !